Annals of hepatology

Keyphrases

Publications

volume 30, number 1, 2024

Maria Stella Franzè, Paul Vigneron, Anna Sessa, Carlo Saitta, Julia Chalaye, Vania Tacher, Alain Luciani, Hélène Regnault, Ancuta Bejan, Rami Rhaiem, Daniele Sommacale, Vincent Leroy, Raffaele Brustia, Giovanni Raimondo, Giuliana Amaddeo
Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy. Annals of hepatology 30 (1) (2024)
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B. Annals of hepatology 30 (1) (2024)

volume 29, number 4, 2024

Shengguang Yan, Lina Yu, Ziren Chen, Dan Xie, Zuli Huang, Shi Ouyang
ZBP1 promotes hepatocyte pyroptosis in acute liver injury by regulating the PGAM5/ROS pathway. Annals of hepatology 29 (4) (2024)

volume 29, number 5, 2024

Enas Kamal, Alaa M Mostafa, Yasser Fouad
MAFLD vs. MASLD: Consensus is unlike evidence! Annals of hepatology 29 (5) (2024)
Tania G Heredia-Torres, Veronica Alvarado-Martínez, Ana R Rincón-Sánchez, Sonia A Lozano-Sepúlveda, Kame A Galán-Huerta, Daniel Arellanos-Soto, Ana M Rivas-Estilla
Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells. Annals of hepatology 29 (5) (2024)
Enas Kamal, Alaa M Mostafa, Yasser Fouad
MAFLD vs. MASLD: Consensus is unlike evidence! Annals of hepatology 29 (5) (2024)
Petr Hříbek, Ondřej Vrtělka, Kateřina Králová, Johana Klasová, Markéta Fousková, Lucie Habartová, Kristýna Kubíčková, Tomáš Kupsa, Tomáš Tůma, Vladimír Setnička, Petr Urbánek
Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients. Annals of hepatology 29 (5) (2024)
Ziyan Pan, Mohammed Eslam
MAFLD or MASLD: Let the evidence decide again. Annals of hepatology 29 (5) (2024)
Nelia Hernandez, Fernando Bessone, Raul Andrade
Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury. Annals of hepatology 29 (5) (2024)
Ignat Drozdov, Benjamin Szubert, Ian A Rowe, Timothy J Kendall, Jonathan A Fallowfield
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records. Annals of hepatology 29 (5) (2024)
Alan I Valderrama-Treviño, Andrés E Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, Natalia Nuño-Lámbarri, Eduardo E Montalvo-Javé
Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct. Annals of hepatology 29 (5) (2024)
Ignat Drozdov, Benjamin Szubert, Ian A Rowe, Timothy J Kendall, Jonathan A Fallowfield
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records. Annals of hepatology 29 (5) (2024)
Mariana M Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Beatriz Barranco-Fragoso, Sandra M Barbalho, Nahum Méndez-Sánchez
NAFLD-MASLD-MAFLD continuum: A swinging pendulum? Annals of hepatology 29 (5) (2024)
Hugo M Oliveira, Helena Pessegueiro Miranda, Francisca Rego, Rui Nunes
Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral. Annals of hepatology 29 (5) (2024)
Mingkai Li, Ying Lin, Hongsheng Yu, Weichun Lin, Jianning Chen, Yidong Yang, Bin Wu
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease. Annals of hepatology 29 (5) (2024)
Petr Hříbek, Ondřej Vrtělka, Kateřina Králová, Johana Klasová, Markéta Fousková, Lucie Habartová, Kristýna Kubíčková, Tomáš Kupsa, Tomáš Tůma, Vladimír Setnička, Petr Urbánek
Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients. Annals of hepatology 29 (5) (2024)
Hugo M Oliveira, Helena Pessegueiro Miranda, Francisca Rego, Rui Nunes
Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral. Annals of hepatology 29 (5) (2024)
Alan I Valderrama-Treviño, Andrés E Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, Natalia Nuño-Lámbarri, Eduardo E Montalvo-Javé
Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct. Annals of hepatology 29 (5) (2024)
Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease. Annals of hepatology 29 (5) (2024)
Mariana M Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Beatriz Barranco-Fragoso, Sandra M Barbalho, Nahum Méndez-Sánchez
NAFLD-MASLD-MAFLD continuum: A swinging pendulum? Annals of hepatology 29 (5) (2024)
Ignat Drozdov, Benjamin Szubert, Ian A Rowe, Timothy J Kendall, Jonathan A Fallowfield
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records. Annals of hepatology 29 (5) (2024)
Mariana M Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Beatriz Barranco-Fragoso, Sandra M Barbalho, Nahum Méndez-Sánchez
NAFLD-MASLD-MAFLD continuum: A swinging pendulum? Annals of hepatology 29 (5) (2024)
Alan I Valderrama-Treviño, Andrés E Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, Natalia Nuño-Lámbarri, Eduardo E Montalvo-Javé
Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct. Annals of hepatology 29 (5) (2024)
Tania G Heredia-Torres, Veronica Alvarado-Martínez, Ana R Rincón-Sánchez, Sonia A Lozano-Sepúlveda, Kame A Galán-Huerta, Daniel Arellanos-Soto, Ana M Rivas-Estilla
Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells. Annals of hepatology 29 (5) (2024)
Ziyan Pan, Mohammed Eslam
MAFLD or MASLD: Let the evidence decide again. Annals of hepatology 29 (5) (2024)
Hugo M Oliveira, Helena Pessegueiro Miranda, Francisca Rego, Rui Nunes
Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral. Annals of hepatology 29 (5) (2024)
Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease. Annals of hepatology 29 (5) (2024)
Graciela Elia Castro Narro, Luis Antonio Díaz, Eric Kauffman Ortega, María Fernanda Bautista Garín, Eira Cerda Reyes, Pindaro Sebastian Martinez Delfin, Juan Pablo Arab, Ramón Bataller
Alcohol-related liver disease: A global perspective. Annals of hepatology 29 (5) (2024)
Graciela Elia Castro Narro, Luis Antonio Díaz, Eric Kauffman Ortega, María Fernanda Bautista Garín, Eira Cerda Reyes, Pindaro Sebastian Martinez Delfin, Juan Pablo Arab, Ramón Bataller
Alcohol-related liver disease: A global perspective. Annals of hepatology 29 (5) (2024)
Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease. Annals of hepatology 29 (5) (2024)
Enas Kamal, Alaa M Mostafa, Yasser Fouad
MAFLD vs. MASLD: Consensus is unlike evidence! Annals of hepatology 29 (5) (2024)
Isabel Campos-Varela, Lluis Castells, Sergi Quiroga, Victor Vargas, Macarena Simon-Talero
Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting. Annals of hepatology 29 (5) (2024)
Nelia Hernandez, Fernando Bessone, Raul Andrade
Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury. Annals of hepatology 29 (5) (2024)
Ziyan Pan, Mohammed Eslam
MAFLD or MASLD: Let the evidence decide again. Annals of hepatology 29 (5) (2024)
Isabel Campos-Varela, Lluis Castells, Sergi Quiroga, Victor Vargas, Macarena Simon-Talero
Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting. Annals of hepatology 29 (5) (2024)
Mingkai Li, Ying Lin, Hongsheng Yu, Weichun Lin, Jianning Chen, Yidong Yang, Bin Wu
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease. Annals of hepatology 29 (5) (2024)
Isabel Campos-Varela, Lluis Castells, Sergi Quiroga, Victor Vargas, Macarena Simon-Talero
Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting. Annals of hepatology 29 (5) (2024)
Petr Hříbek, Ondřej Vrtělka, Kateřina Králová, Johana Klasová, Markéta Fousková, Lucie Habartová, Kristýna Kubíčková, Tomáš Kupsa, Tomáš Tůma, Vladimír Setnička, Petr Urbánek
Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients. Annals of hepatology 29 (5) (2024)
Petr Hříbek, Ondřej Vrtělka, Kateřina Králová, Johana Klasová, Markéta Fousková, Lucie Habartová, Kristýna Kubíčková, Tomáš Kupsa, Tomáš Tůma, Vladimír Setnička, Petr Urbánek
Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients. Annals of hepatology 29 (5) (2024)
Tania G Heredia-Torres, Veronica Alvarado-Martínez, Ana R Rincón-Sánchez, Sonia A Lozano-Sepúlveda, Kame A Galán-Huerta, Daniel Arellanos-Soto, Ana M Rivas-Estilla
Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells. Annals of hepatology 29 (5) (2024)
Nelia Hernandez, Fernando Bessone, Raul Andrade
Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury. Annals of hepatology 29 (5) (2024)
Mingkai Li, Ying Lin, Hongsheng Yu, Weichun Lin, Jianning Chen, Yidong Yang, Bin Wu
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease. Annals of hepatology 29 (5) (2024)

volume 29, number 6, 2024

Fatima Rodriguez-Alvarez, Blanca Zuleima Mota-Ayala, Ramiro Villavicencio-Martínez, Eric Kauffman-Ortega, Lucero Selene Téllez-Morán, Graciela Castro-Narro, Eleazar Ignacio-Alvarez, Jesús Alejandro Gabutti-Thomas, Carlos Moctezuma-Velazquez
Limited utility of routine bone scintigraphy in the staging of patients with hepatocellular carcinoma: A cross-sectional study. Annals of hepatology 29 (6) (2024)
Juan F Ortiz-Treviño, Alma L Kuljacha-Gastélum, Alejandro Tovar-Durán, Martha E Wade-Isidro
Stroop test, Quickstroop, and the 1-min animal naming test for minimal hepatic encephalopathy diagnosis: A multicenter study in Mexico. Annals of hepatology 29 (6) (2024)
Jui-Hsiang Hung, Chiao-Feng Teng, Hsu-Chin Hung, Yi-Lin Chen, Pin-Jun Chen, Chung-Liang Ho, Cheng-Hsiang Chuang, Wenya Huang
Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies. Annals of hepatology 29 (6) (2024)
Feifan He, Zhongming He, Caoye Wang
A novel role of AIM2 inflammasome-mediated pyroptosis in radiofrequency ablation of hepatocellular carcinoma. Annals of hepatology 29 (6) (2024)
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P H Drenth, Maria Papp, Nikolaos K Gatselis, Kalliopi Zachou, Matthias Pinter, Bernhard Scheiner, Arndt Vogel, Martha M Kirstein, Fabian Finkelmeier, Oliver Waidmann, Arndt Weinmann, Piotr Milkiewicz, Douglas Thorburn, Neil Halliday, Ana Lleo, Samuel Huber, George N Dalekos, Ansgar W Lohse, Henning Wege, Johann von Felden, Kornelius Schulze
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma. Annals of hepatology 29 (6) (2024)
Mariana M Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Nahum Méndez-Sánchez
The myth of the stigma of fatty liver: What does the evidence show? Annals of hepatology 29 (6) (2024)
Junnv Xu, Kun Liu, Zhixun Gong, Jinchen Liu, Haifeng Lin, Bo Lin, Wei Li, Mingyue Zhu, Mengsen Li
IL-6/STAT3 signaling pathway induces prostate apoptosis response protein-4(PAR-4) to stimulate malignant behaviors of hepatocellular carcinoma cells. Annals of hepatology 29 (6) (2024)
Kamyar Ghabili, Austin-Marley Windham-Herman, Menelaos Konstantinidis, Nikitha Murali, Tabea Borde, Lucas C Adam, Fabian Laage-Gaupp, MingDe Lin, Julius Chapiro, Christos Georgiades, Nariman Nezami
Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases. Annals of hepatology 29 (6) (2024)